New York (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization to a Zika test from Roche that runs on the firm's LightCycler 480 Instrument II or Cobas z 480 Analyzer.

The LightMix Zika real-time RT-PCR Test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect viral RNA in plasma or serum of patients meeting US Centers for Disease Control and Prevention clinical or epidemiological criteria, Roche said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.